Granuloma: A High-Yield USMLE Pathology & Immunology Review
A granuloma is a specific pattern of chronic inflammation in which macrophages transform into epithelioid cells and wall off an antigen the body can phagocytose but cannot destroy. It is a Type IV, cell-mediated (Th1) process, and on the exam the granuloma itself is never the answer — the necrosis pattern at its center is the discriminating feature that drives the differential.
Pathophysiology
Granulomas form when a persistent stimulus — an unresolved infection (e.g., mycobacteria, fungi), autoimmunity, a prolonged toxic exposure like silica, or a foreign body — cannot be cleared by ordinary phagocytosis. Cell-mediated immunity engages: Th1 cytokines activate macrophages, which transform into epithelioid cells and sometimes fuse into multinucleated giant cells to wall off the offending antigen. TNF-α is required to maintain this architecture, which is why blocking it reactivates walled-off organisms. When macrophages cannot fully digest an organism, caseous (cheese-like) necrosis accumulates at the center, signaling an infectious mycobacterial or fungal cause.
Presentation
- A histologic pattern of chronic inflammation dominated by lymphocytes, plasma cells, and macrophages, evolving over weeks to years with simultaneous tissue destruction and attempted repair.
- Sarcoidosis presentation: a young African American woman with bilateral hilar lymphadenopathy whose biopsy shows non-caseating granulomas.
- Reactivation tuberculosis presentation: an upper-lobe cavitary lung lesion with caseating granulomas containing Langhans giant cells.
- Recurrent abscesses and fungal (e.g., Aspergillus) infections with granuloma formation in chronic granulomatous disease, a phagocyte oxidative-burst defect.
- Reactivation of latent TB or Listeria in patients started on TNF-α inhibitors, high-dose steroids, or transplant immunosuppression.
Diagnosis
- Tissue biopsy demonstrating epithelioid macrophages, sometimes with multinucleated (Langhans) giant cells — confirming granulomatous inflammation.
- Assessment of the central necrosis pattern: caseous necrosis points toward mycobacteria or fungi, while non-caseating granulomas shift the differential toward sarcoidosis, Crohn's disease, berylliosis, and foreign-body reaction.
- When recurrent Staph aureus/Aspergillus abscesses and granulomas suggest chronic granulomatous disease, order a DHR (respiratory burst) test to confirm the NADPH oxidase defect.
- Identify the persistent stimulus driving the chronic/granulomatous response — infection, autoimmunity, toxic exposure, or foreign body.
Management
- Direct therapy at the underlying stimulus — treat the causative organism in infectious (caseating) granulomas.
- Screen for latent TB (and hepatitis) before starting TNF-α inhibitors, because TNF-α is required for granuloma maintenance and its blockade reactivates latent mycobacterial and Listeria infection.
High-yield
- Granulomatous inflammation = macrophages transformed into epithelioid cells, sometimes fused into multinucleated giant cells, walling off an antigen they can phagocytose but not destroy.
- The necrosis pattern inside the granuloma is the discriminating feature, NOT the granuloma itself.
- Caseating granulomas → infection (mycobacteria, fungi); non-caseating granulomas → sarcoidosis, Crohn's disease, berylliosis, foreign body.
- Granuloma formation is a Type IV, cell-mediated (Th1) response; TNF-α maintains granulomas — anti-TNF biologics reactivate latent TB.
- Facultative intracellular bacteria (Mycobacterium, Listeria, Salmonella, Legionella, Brucella, Francisella) are contained by cell-mediated immunity and granuloma formation.
- Chronic granulomatous disease: NADPH oxidase deficiency, catalase-positive organisms (Staph aureus, Aspergillus, Burkholderia), recurrent abscesses and granulomas.
Pitfalls
- Stopping at 'granuloma' as the diagnosis — the granulomatous response is identical across diseases; you must read the center (caseation) to separate infection from sarcoidosis/Crohn's/foreign body.
- Forgetting to screen for latent TB before anti-TNF therapy — losing TNF-α collapses granuloma maintenance and reactivates latent mycobacterial/Listeria infection.
- Overlooking impaired cell-mediated immunity (HIV with low CD4, high-dose steroids, transplant immunosuppression) as the reason facultative intracellular organisms disseminate.
- Assuming all granulomatous disease is infectious — non-infectious drivers include autoimmunity, silicosis, berylliosis, and foreign-body reactions.
Don't just memorize Granuloma (Granulomatous Inflammation) — practice reasoning through it on branching cases where your decisions shape the patient.